The Journal of Urology
Volume 183, Issue 1 , Pages 34-42, January 2010

800 Laparoscopic Partial Nephrectomies: A Single Surgeon Series

  • Inderbir S. Gill

      Affiliations

    • USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California
    • Financial interest and/or other relationship with Hansen Medical.
    • Corresponding Author InformationCorrespondence: 1441 Eastlake Ave., Suite 7416, Keck School of Medicine, University of Southern California, Los Angeles, California 90089 (telephone: 323-865-3708; FAX: 323-865-0120)
  • ,
  • Kazumi Kamoi

      Affiliations

    • Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Monish Aron

      Affiliations

    • Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Mihir M. Desai

      Affiliations

    • Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio
    • Financial interest and/or other relationship with Hansen Medical and Baxter.

Received 1 April 2009 published online 12 November 2009.

Purpose

We hypothesized that from 1999 to 2008 patient and tumor selection criteria, perioperative outcomes, complications and renal function outcomes may have evolved significantly in 800 laparoscopic partial nephrectomies.

Materials and Methods

We retrospectively divided 800 patients who underwent laparoscopic partial nephrectomy for tumor, as done by 1 surgeon, into 3 chronologic eras, including era 1—276 from September 1999 to December 2003, era 2—289 from January 2004 to December 2006 and era 3—235 from January 2007 through November 2008. We evaluated prospectively collected data on tumor characteristics, perioperative outcomes and renal function outcomes.

Results

When comparing eras 1 to 3, tumors in the most recent era were larger, more commonly 4 cm or greater, and central, and less often peripheral and less than 4 cm (each p value significant). Despite increasing tumor complexity warm ischemia time was shorter (31.9, 31.6 and 14.4 minutes, respectively, p <0.0001), and the overall rates of postoperative and urological complications were significantly lower in the most recent era. The rate of parenchymal margins positive for cancer was 1%, 1% and 0.6%, respectively. Renal function outcomes were superior in era 3, as reflected by a lesser decrease in the estimated glomerular filtration rate (18%, 20% and 11%, respectively). In the 744 patients with pathologically confirmed malignancy 5-year overall, cancer specific and recurrence-free survival was 90%, 99% and 97%, respectively.

Conclusions

During our 9-year experience with 800 consecutive laparoscopic partial nephrectomies tumor characteristics and surgical outcomes evolved. Despite increasing tumor complexity in contemporary practice 3 key outcomes of laparoscopic partial nephrectomy improved significantly, including ischemia time, complications and renal function. We now routinely offer laparoscopic partial nephrectomy for most tumors hitherto reserved for open nephron sparing surgery.

Key Words: kidney, carcinoma, renal cell, nephrectomy, laparoscopy, outcome assessment (health care)

Abbreviations and Acronyms: CT, computerized tomography, eGFR, estimated glomerular filtration rate, LPN, laparoscopic partial nephrectomy, LRN, laparoscopic radical nephrectomy, MDRD, modification of diet in renal disease, RCC, renal cell carcinoma, WIT, warm ischemia time

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received institutional review board approval.

 Supplementary material for this article can be obtained at http://www.uscurology.com.

 For another article on a related topic see page 333.

PII: S0022-5347(09)02327-1

doi:10.1016/j.juro.2009.08.114

Refers to article:

  • Immunological Response to Renal Cryoablation in an In Vivo Orthotopic Renal Cell Carcinoma Murine Model , 16 November 2009

    Surena F. Matin, Padmanee Sharma, Inderbir S. Gill, Charles Tannenbaum, Michael G. Hobart, Andrew C. Novick, James H. Finke
    The Journal of Urology January 2010 (Vol. 183, Issue 1, Pages 333-338)

The Journal of Urology
Volume 183, Issue 1 , Pages 34-42, January 2010